Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
Shinji Saiki(University of Tsukuba), Nobutaka Hattori(RIKEN Center for Brain Science), Kei‐ichi Ishikawa(Tokyo University of the Arts), Yoko Imamichi(Juntendo University), Takahiro Koinuma(Juntendo University), Akio Mori(Juntendo University), Taku Hatano(Juntendo University), Shuko Nojiri(Juntendo University), Miho Nagumo(Juntendo University), Ayami Okuzumi(Juntendo University), Takeshi Fukuhara(Tokyo University of Pharmacy and Life Sciences), Kazuo Yamashiro(Juntendo University), Norihiko Furuya(Juntendo University), Yutaka Oji(Juntendo University), Motoki Fujimaki(Juntendo University), Taku Amo(National Defense Academy of Japan)
Cited by 143
Related Papers
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k